HRA Pharma Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Employees
-
277
- Latest Deal Type
-
M&A
- Financing Rounds
-
5
- Investments
-
5
HRA Pharma General Information
Description
Developer of pharmaceutical medicines specially designed for women's health and endocrinology. The company's therapeutic products are particularly used in emergency contraception, uterine fibroids and rare endocrine disorders such as Cushing's syndrome and advanced adrenal cortical carcinoma, enabling doctors to satisfy critical patient needs and improve patient health.
Contact Information
Website
www.hra-pharma.comCorporate Office
- 200 avenue
- Châtillon
- 92320 Paris
- France
Corporate Office
- 200 avenue
- Châtillon
- 92320 Paris
- France
HRA Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
HRA Pharma Comparisons
Industry
Financing
Details
HRA Pharma Competitors (25)
One of HRA Pharma’s 25 competitors is Fervent Pharmaceuticals, a Formerly Angel backed company based in Greenville, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Fervent Pharmaceuticals | Formerly Angel backed | Greenville, NC | ||||
| Kainova Therapeutics | Venture Capital-Backed | Montreal, Canada | ||||
| Orbsen Therapeutics | Formerly PE-Backed | Galway, Ireland | ||||
| Coave Therapeutics | Venture Capital-Backed | Paris, France | ||||
| ACADIA Pharmaceuticals | Formerly VC-backed | San Diego, CA |
HRA Pharma Patents
HRA Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-3174989-A3 | Mobile gas leak detection system | Pending | 12-May-2025 | ||
| US-20200316091-A1 | Method for providing contraception | Inactive | 05-Apr-2019 | ||
| EP-3847187-A1 | Zp3 fragments in immunotherapy of ovarian cancer | Inactive | 03-Sep-2018 | ||
| US-20210317165-A1 | Zp3 fragments in immunotherapy of ovarian cancer | Inactive | 03-Sep-2018 | ||
| WO-2020048924-A1 | Zp3 fragments in immunotherapy of ovarian cancer | Inactive | 03-Sep-2018 | C07K14/705 |
HRA Pharma Signals
HRA Pharma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
HRA Pharma Investments (5)
HRA Pharma’s most recent deal was a Joint Venture with HRA Pharma China. The deal was made on 13-Jan-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| HRA Pharma China | 13-Jan-2020 | Joint Venture | Pharmaceuticals | ||
| Mederma | 27-May-2019 | Buyout/LBO | Personal Products | ||
| Bristol-Myers Squibb Company (Lysodren) | 14-Mar-2018 | Buyout/LBO | Buildings and Property | ||
| Johnson & Johnson (Compeed business) | 20-Sep-2017 | Buyout/LBO | Personal Products | ||
| Embera NeuroTherapeutics | 29-Sep-2015 | Later Stage VC | Drug Discovery |
HRA Pharma Exits (1)
HRA Pharma’s most recent exit was on 29-Sep-2015 from Embera NeuroTherapeutics. The exit was categorized as with 6 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Embera NeuroTherapeutics | 29-Sep-2015 | Completed |
|
HRA Pharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Mederma | Raleigh, NC | 1997 |
HRA Pharma FAQs
-
When was HRA Pharma founded?
HRA Pharma was founded in 1996.
-
Where is HRA Pharma headquartered?
HRA Pharma is headquartered in Paris, France.
-
What is the size of HRA Pharma?
HRA Pharma has 277 total employees.
-
What industry is HRA Pharma in?
HRA Pharma’s primary industry is Pharmaceuticals.
-
Is HRA Pharma a private or public company?
HRA Pharma is a Private company.
-
What is the current valuation of HRA Pharma?
The current valuation of HRA Pharma is .
-
What is HRA Pharma’s current revenue?
The current revenue for HRA Pharma is .
-
How much funding has HRA Pharma raised over time?
HRA Pharma has raised $501M.
-
Who are HRA Pharma’s investors?
Astorg, Goldman Sachs Asset Management, and The Riverside Company have invested in HRA Pharma.
-
Who are HRA Pharma’s competitors?
Fervent Pharmaceuticals, Kainova Therapeutics, Orbsen Therapeutics, Coave Therapeutics, and ACADIA Pharmaceuticals are some of the 25 competitors of HRA Pharma.
-
When was HRA Pharma acquired?
HRA Pharma was acquired on 29-Apr-2022.
-
Who acquired HRA Pharma?
HRA Pharma was acquired by Perrigo Company.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process